MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LTRN has $7,223,067 in assets. $3,777,366 in debts. $4,917,796 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
186.83%
Quick Ratio
186.83%
Cash Ratio
130.19%
Debt to Asset Ratio
52.30%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses & other current...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
4,917,796 4,422,838 8,389,486 6,061,408
Marketable securities
1,405,057 5,696,386 3,973,090 9,840,366
Prepaid expenses & other current assets
734,407 683,948 1,098,429 1,299,016
Total current assets
7,057,260 10,803,172 13,461,005 17,200,790
Property and equipment, net
28,022 31,875 35,977 39,524
Operating lease right-of-use assets
56,868 75,595 93,090 143,240
Deferred offering costs
54,827 88,431 --
Other assets
26,090 36,738 36,738 36,738
Total assets
7,223,067 11,035,811 13,626,810 17,420,292
Accounts payable and accrued expenses
3,718,290 4,423,048 3,946,018 4,752,848
Operating lease liabilities, current
59,076 78,539 93,954 131,515
Total current liabilities
3,777,366 4,501,587 4,039,972 4,884,363
Operating lease liabilities, net of current portion
---13,524
Preferred stock (1,000,000 authorized at june 30, 2025 and december 31, 2024 .0001 par value) (zero shares issued and outstanding at june 30, 2025 and december 31, 2024)
---0
Total liabilities
3,777,366 4,501,587 4,039,972 4,897,887
Common stock (25,000,000 authorized at march 31, 2026 and december 31, 2025 .0001 par value) (11,254,697 shares issued and outstanding at march 31, 2026 and december 31, 2025)
1,125 1,125 1,104 1,078
Additional paid-in capital
99,954,439 99,652,724 98,616,239 97,366,699
Accumulated other comprehensive (loss) income
-35,637 25,430 40,333 48,043
Accumulated deficit
-96,474,226 -93,145,055 -89,070,838 -84,893,415
Total stockholders equity
3,445,701 6,534,224 9,586,838 12,522,405
Total liabilities and stockholders equity
7,223,067 11,035,811 13,626,810 17,420,292
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,917,796 Marketable securities$1,405,057 Prepaid expenses & othercurrent assets$734,407 Total current assets$7,057,260 Operating leaseright-of-use assets$56,868 Deferred offering costs$54,827 Property and equipment,net$28,022 Other assets$26,090 Total assets$7,223,067 Total liabilities andstockholders equity$7,223,067 Total liabilities$3,777,366 Total stockholdersequity$3,445,701 Accumulated deficit-$96,474,226 Accumulated othercomprehensive (loss) income-$35,637 Total currentliabilities$3,777,366 Additional paid-in capital$99,954,439 Common stock(25,000,000 authorized at...$1,125 Accounts payable andaccrued expenses$3,718,290 Operating leaseliabilities, current$59,076

Lantern Pharma Inc. (LTRN)

Lantern Pharma Inc. (LTRN)